The effects of β-glucans on dendritic cells and implications for cancer therapy

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 5, 2013, Pages 689-698

  Albeituni, Sabrin H ^a   Yan, Jun ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Beta glucans; Dectin 1; Dendritic cells (DC); Tumor immunotherapy

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; B7 ANTIGEN; BETA GLUCAN; CD40 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; CURDLAN; DECTIN 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; LACTOSYLCERAMIDE; MYELOID DIFFERENTIATION FACTOR 88; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; DENDRITIC CELL; DRUG NOMENCLATURE; HUMAN; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA-GLUCANS; DENDRITIC CELLS; HUMANS; NEOPLASMS;

EID: 84880163021     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313050003     Document Type: Article

References (108)

1. Yan, J.; Allendorf, D.J.; Brandley, B. Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert opin. Biol. Ther., 2005, 5 (5), 691-702.
2. Di Luzio, N.R.; Williams, D.L.; McNamee, R.B.; Edwards, B.F.; Kitahama, A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. International journal of cancer. J. Int. Du Cancer, 1979, 24 (6), 773-9.
3. Riggi, S.J.; Di Luzio, N.R. Identification of a reticuloendothelial stimulating agent in zymosan. The Am. J. Physiol., 1961, 200, 297-300.
4. Medzhitov, R. Approaching the asymptote: 20 years later. Immunity, 2009, 30 (6), 766-75.
5. Janeway, C.A., Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor symposia on quantitative biology, 1989, 54 Pt 1, 1-13.
6. Poltorak, A.H. Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: Mutations in Tlr4 gene. Science, 1998, 282 (5396), 2085.
7. Xia, Y.; Vetvicka, V.; Yan, J.; Hanikyrova, M.; Mayadas, T.; Ross, G.D., The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3bopsonized target cells. J. Immunol., 1999, 162 (4), 2281-90.
8. Zimmerman, J.W.; Lindermuth, J.; Fish, P.A.; Palace, G.P.; Stevenson, T.T.; DeMong, D.E. A novel carbohydrateglycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem., 1998, 273 (34), 22014-20.
9. Rice, P.J.; Kelley, J.L.; Kogan, G.; Ensley, H.E.; Kalbfleisch, J.H.; Browder, I.W.; Williams, D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1->3)-beta-Dglucans. J. Leukocyte Biol., 2002, 72 (1), 140-6.
10. Ariizumi, K.; Shen, G.L.; Shikano, S.; Xu, S.; Ritter, R., 3rd; Kumamoto, T.; Edelbaum, D.; Morita, A.; Bergstresser, P.R.; Takashima, A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem., 2000, 275 (26), 20157-67.
11. Qi, C.; Cai, Y.; Gunn, L.; Ding, C.; Li, B.; Kloecker, G.; Qian, K.; Vasilakos, J.; Saijo, S.; Iwakura, Y.; Yannelli, J.R.; Yan, J., Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived betaglucans. Blood, 2011, 117 (25), 6825-36.
12. Li, B.; Cai, Y.; Qi, C.; Hansen, R.; Ding, C.; Mitchell, T.C.; Yan, J. Orally administered particulate beta-glucan modulates tumorcapturing dendritic cells and improves antitumor T-cell responses in cancer. Clin. Cancer Res., 2010, 16 (21), 5153-64.
13. Hong, F.; Yan, J.; Baran, J.T.; Allendorf, D.J.; Hansen, R.D.; Ostroff, G.R.; Xing, P.X.; Cheung, N.K.; Ross, G.D. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol., 2004, 173 (2), 797-806.
14. IUPAC Compendium of Chemical Terminology 2nd ed.; 1997.
15. Polysaccharide Nomenclature. Eu. J. Biochem., 1982, 126 (3), 439-441.
16. Deng, C.; Hu, Z.; Fu, H.; Hu, M.; Xu, X.; Chen, J. Chemical analysis and antioxidant activity in vitro of a beta-D-glucan isolated from Dictyophora indusiata. Int. J. Biol. Macromol., 2012.
17. Kim, H.J.; White, P.J. In Vitro digestion rate and estimated glycemic index of oat flours from typical and high beta-glucan oat lines. J. Agricul. Food Chem., 2012.
18. Tanioka, A.; An, W.W.; Kuge, T.; Tsubaki, K.; Nakaya, K. Barley low molecular weight beta-glucan potently induces maturation of mouse dendritic cells. Anticancer Res., 2011, 31 (5), 1647-51.
19. Skov, J.; Kania, P.W.; Holten-Andersen, L.; Fouz, B.; Buchmann, K. Immunomodulatory effects of dietary beta-1,3-glucan from Euglena gracilis in rainbow trout (Oncorhynchus mykiss) immersion vaccinated against Yersinia ruckeri. Fish Shellfish Immunol., 2012.
20. Monteiro, M.A.; Slavic, D.; St Michael, F.; Brisson, J.R.; MacInnes, J.I.; Perry, M.B. The first description of a (1-> 6)-beta-D-glucan in prokaryotes: (1-> 6)-beta-D-glucan is a common component of actinobacillus suis and is the basis for a serotyping system. Carbohydr. Res., 2000, 329 (1), 121-30.
21. Delmer, D.P. Cellulose biosynthesis: Exciting times for a difficult field of study. Annual review of plant physiology and plant molecular biology 1999, 50, 245-276.
22. Glaser, L. The synthesis of cellulose in cell-free extracts of Acetobacter xylinum. J. Biol. Chem., 1958, 232 (2), 627-36.
23. Ross, P.; Mayer, R.; Benziman, M., Cellulose biosynthesis and function in bacteria. Microbiological reviews 1991, 55 (1), 35-58.
24. Cabib, E.; Blanco, N.; Arroyo, J. Presence of a large beta(1-3)glucan linked to chitin at the Saccharomyces cerevisiae motherbud neck suggests involvement in localized growth control. Eukaryotic cell 2012, 11 (4), 388-400.
25. Arellano-Reynoso, B.; Lapaque, N.; Salcedo, S.; Briones, G.; Ciocchini, A. E.; Ugalde, R.; Moreno, E.; Moriyon, I.; Gorvel, J. P. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nature Immunol., 2005, 6 (6), 618-25.
26. Nett, J.; Lincoln, L.; Marchillo, K.; Massey, R.; Holoyda, K.; Hoff, B.; VanHandel, M.; Andes, D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother., 2007, 51 (2), 510-20.
27. Sinskey, S.J.C.K.R.A.J. Glucan compositions and process preparations thereof. 1989.
28. Chihara, G.; Maeda, Y.; Hamuro, J.; Sasaki, T.; Fukuoka, F. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature 1969, 222 (5194), 687-8.
29. Chihara, G.; Hamuro, J.; Maeda, Y.; Arai, Y.; Fukuoka, F. Antitumor polysaccharide derived chemically from natural glucan (pachyman). Nature, 1970, 225 (5236), 943-4.
30. Amemura, A.; Hisamatsu, M.; Harada, T. Spontaneous mutation of polysaccharide production in Alcaligenes faecalis var. myxogenes 10C3. Appl. Environ. Microbiol., 1977, 34 (6), 617-20.
31. Sasaki, T.; Abiko, N.; Sugino, Y.; Nitta, K., Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its aciddegraded products. Cancer Res., 1978, 38 (2), 379-83.
32. Ohno, N.; Kurachi, K.; Yadomae, T. Antitumor activity of a highly branched (1--3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395. J. Pharmacobio-dynamics, 1987, 10(9), 478-86.
33. Cheung, N. K.; Modak, S.; Vickers, A.; Knuckles, B. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunotherapy, 2002, 51 (10), 557-64.
34. Jamas, S.O.; Easson, G.R. D Glucan delivery system and adjuvant. 1990.
35. Li, B.; Cramer, D.; Wagner, S.; Hansen, R.; King, C.; Kakar, S.; Ding, C.; Yan, J. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways. Clin. Immunol.; 2007, 124 (2), 170-81.
36. Jamas, S.E.D.; Ostroff, GR. Method for producing neutral glucans for pharmaceutical applications. 5,322,841, 1994.
37. Jamas, S.E.D.; Ostroff, GR. Glucan preparation. 5,622,939, 1997.
38. Kelly, L.S.; Dobson, E.L.; Finney, C.R.; Hirsch, J.D. Proliferation of the reticuloendothelial system in the liver. Am. J. Physiol., 1960, 198, 1134-8.
39. Pillemer, L.; Schoenberg, M.D.; Blum, L.; Wurz, L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science, 1955, 122 (3169), 545-9.
40. Hourcade, D.E. Properdin and complement activation: A fresh perspective. Curr. Drug Targets, 2008, 9 (2), 158-64.
41. Pillemer, L.; Blum, L.; Pensky, J.; Lepow, I.H. The requirement for magnesium ions in the inactivation of the third component of human complement (C'3) by insoluble residues of yeast cells (zymosan). J. Immunol., 1953, 71(5), 331-8.
42. Brade, V.; Lee, G.D.; Nicholson, A.; Shin, H.S.; Mayer, M.M. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3-and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway. J. Immunol., 1973, 111(5), 1389-400.
43. Ara, Y.; Saito, T.; Takagi, T.; Hagiwara, E.; Miyagi, Y.; Sugiyama, M.; Kawamoto, S.; Ishii, N.; Yoshida, T.; Hanashi, D.; Koshino, T.; Okada, H.; Okuda, K. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology, 2001, 103(1), 98-105.
44. Pillemer, L.; Ross, O.A. Alterations in serum properdin levels following injection of Zymosan. Science, 1955, 121 (3151), 732-3.
45. Nicholson, A.; Brade, V.; Lee, G.D.; Shin, H.S.; Mayer, M.M. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly. J. Immunol., 1974, 112 (3), 1115-23.
46. Spitzer, D.; Mitchell, L.M.; Atkinson, J.P.; Hourcade, D.E. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol., 2007, 179 (4), 2600-8.
47. Diller, I.C.; Mankowski, Z.T.; Fisher, M.E. The effect of yeast polysaccharides on mouse tumors. Cancer Res., 1963, 23, 201-8.
48. Sherwood, E.R.; Williams, D.L.; McNamee, R.B.; Jones, E.L.; Browder, I.W.; Di Luzio, N.R. In vitro tumoricidal activity of resting and glucan-activated Kupffer cells. J. Leukocyte Biol., 1987, 42 (1), 69-75.
49. Morikawa, K.; Takeda, R.; Yamazaki, M.; Mizuno, D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res., 1985, 45 (4), 1496-501.
50. Scaringi, L.; Marconi, P.; Boccanera, M.; Tissi, L.; Bistoni, F.; Cassone, A. Cell wall components of Candida albicans as immunomodulators: Induction of natural killer and macrophagemediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J. General Microbiol., 1988, 134 (5), 1265-74.
51. Suzuki, M.; Kikuchi, T.; Takatsuki, F.; Hamuro, J., Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells. Cancer Immunol. Immunotherapy, 1994, 38 (1), 1-8.
52. Steinman, R.M.; Cohn, Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med., 1973, 137 (5), 1142-62.
53. Ross, G.D.; Cain, J.A.; Lachmann, P.J. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol., 1985, 134 (5), 3307-15.
54. Ezekowitz, R.A.; Sim, R.B.; Hill, M.; Gordon, S. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J. Exp. Med., 1984, 159 (1), 244-60.
55. Thornton, B.P.; Vetvicka, V.; Pitman, M.; Goldman, R.C.; Ross, G. D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 1996, 156 (3), 1235-46.
56. Xia, Y.; Ross, G.D. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18). J. Immunol, 1999, 162 (12), 7285-93.
57. Yan, J.; Allendorf, D.J.; Li, B.; Yan, R.; Hansen, R.; Donev, R. The role of membrane complement regulatory proteins in cancer immunotherapy. Adv. Exp. Med. Biol., 2008, 632, 159-74.
58. Driscoll, M.; Hansen, R.; Ding, C.; Cramer, D.E.; Yan, J. Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biol. Therapy, 2009, 8 (3), 218-25.
59. Hong, F.; Hansen, R.D.; Yan, J.; Allendorf, D.J.; Baran, J.T.; Ostroff, G.R.; Ross, G.D. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res., 2003, 63 (24), 9023-31.
60. Vetvicka, V.; Thornton, B.P.; Wieman, T.J.; Ross, G.D. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). J. Immunol., 1997, 159 (2), 599-605.
61. Li, B.; Allendorf, D.J.; Hansen, R.; Marroquin, J.; Ding, C.; Cramer, D.E.; Yan, J. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J. Immunol., 2006, 177 (3), 1661-9.
62. Li, B.; Allendorf, D.J.; Hansen, R.; Marroquin, J.; Cramer, D.E.; Harris, C.L.; Yan, J. Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55. Cancer Res., 2007, 67 (15), 7421-30.
63. Thivierge, M.; Stankova, J.; Rola-Pleszczynski, M. Cysteinylleukotriene receptor type 1 expression and function is downregulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. J. Immunol., 2009, 183 (10), 6778-87.
64. Carmona, E.M.; Kottom, T.J.; Hebrink, D.M.; Moua, T.; Singh, R. D.; Pagano, R.E.; Limper, A.H. Glycosphingolipids mediate pneumocystis cell wall beta-glucan activation of the IL-23/IL-17 axis in human dendritic cells. Am. J. Respir. Cell Mol. Biol., 2012.
65. Carmona, E.M.; Lamont, J.D.; Xue, A.; Wylam, M.; Limper, A.H. Pneumocystis cell wall beta-glucan stimulates calcium-dependent signaling of IL-8 secretion by human airway epithelial cells. Respir. Res., 2010, 11, 95.
66. Carmona, E.M.; Vassallo, R.; Vuk-Pavlovic, Z.; Standing, J.E.; Kottom, T.J.; Limper, A.H. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J. Immunol., 2006, 177 (1), 459-67.
67. Evans, S.E.; Hahn, P.Y.; McCann, F.; Kottom, T.J.; Pavlovic, Z.V.; Limper, A.H. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am. J. Respir. Cell Mol. Biol., 2005, 32 (6), 490-7.
68. Evans, S.E.; Kottom, T.J.; Pagano, R.E.; Limper, A.H. Primary alveolar epithelial cell surface membrane microdomain function is required for Pneumocystis beta-glucan-induced inflammatory responses. Innate immun., 2012.
69. Goldstein, J.L.; Ho, Y.K.; Basu, S.K.; Brown, M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Nat. Acad. Sci. USA, 1979, 76 (1), 333-7.
70. Vereschagin, E.I.; van Lambalgen, A.A.; Dushkin, M.I.; Schwartz, Y.S.; Polyakov, L.; Heemskerk, A.; Huisman, E.; Thijs, L.G.; van den Bos, G.C. Soluble glucan protects against endotoxin shock in the rat: the role of the scavenger receptor. Shock, 1998, 9 (3), 193-8.
71. Dushkin, M.I.; Safina, A.F.; Vereschagin, E.I.; Schwartz, Y.S. Carboxymethylated beta-1,3-glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages In Vitro and modulates their plasma clearance In Vivo. Cell Biochem. Funct., 1996, 14 (3), 209-217.
72. Leake, D.S.; May, G.; Soyombo, A.A.; Nasr-Esfahani, M.H. The effect of macrophage stimulation on the uptake of acetylated lowdensity lipoproteins. Biochim. Biophys. Acta, 1989, 1005 (2), 196-200.
73. Wang, R.; Chandawarkar, R.Y. Phagocytosis of fungal agents and yeast via macrophage cell surface scavenger receptors. J. Surgical Res., 2010, 164 (2), e273-9.
74. Ohtani, K.; Suzuki, Y.; Eda, S.; Kawai, T.; Kase, T.; Keshi, H.; Sakai, Y.; Fukuoh, A.; Sakamoto, T.; Itabe, H.; Suzutani, T.; Ogasawara, M.; Yoshida, I.; Wakamiya, N. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem., 2001, 276 (47), 44222-8.
75. Jozefowski, S.; Yang, Z.; Marcinkiewicz, J.; Kobzik, L. Scavenger receptors and beta-glucan receptors participate in the recognition of yeasts by murine macrophages. Inflamm. Res., 2012, 61 (2), 113-26.
76. Brown, G.D.; Gordon, S. Immune recognition. A new receptor for beta-glucans. Nature 2001, 413 (6851), 36-7.
77. Taylor, P.R.; Brown, G.D.; Reid, D.M.; Willment, J.A.; Martinez-Pomares, L.; Gordon, S.; Wong, S.Y. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol., 2002, 169 (7), 3876-82.
78. Brown, G.D.; Taylor, P.R.; Reid, D.M.; Willment, J.A.; Williams, D.L.; Martinez-Pomares, L.; Wong, S.Y.; Gordon, S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med., 2002, 196 (3), 407-12.
79. Reid, D.M.; Montoya, M.; Taylor, P.R.; Borrow, P.; Gordon, S.; Brown, G.D.; Wong, S.Y. Expression of the beta-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J. Leukocyte Biol., 2004, 76 (1), 86-94.
80. Palma, A.S.; Feizi, T.; Zhang, Y.; Stoll, M.S.; Lawson, A.M.; Diaz-Rodriguez, E.; Campanero-Rhodes, M.A.; Costa, J.; Gordon, S.; Brown, G.D.; Chai, W. Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J. Biol. Chem., 2006, 281 (9), 5771-9.
81. Taylor, P.R.; Tsoni, S.V.; Willment, J.A.; Dennehy, K.M.; Rosas, M.; Findon, H.; Haynes, K.; Steele, C.; Botto, M.; Gordon, S.; Brown, G.D. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nature Immunol., 2007, 8 (1), 31-8.
82. Willment, J.A.; Gordon, S.; Brown, G.D. Characterization of the human beta-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem., 2001, 276 (47), 43818-23.
83. Grunebach, F.; Weck, M. M.; Reichert, J.; Brossart, P. Molecular and functional characterization of human Dectin-1. Exp. Hematol., 2002, 30 (11), 1309-15.
84. Willment, J.A.; Marshall, A.S.; Reid, D.M.; Williams, D.L.; Wong, S.Y.; Gordon, S.; Brown, G.D. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eu. J. Immunol., 2005, 35 (5), 1539-47.
85. Weck, M.M.; Appel, S.; Werth, D.; Sinzger, C.; Bringmann, A.; Grunebach, F.; Brossart, P. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood, 2008, 111 (8), 4264-72.
86. Goodridge, H.S.; Reyes, C.N.; Becker, C.A.; Katsumoto, T.R.; Ma, J.; Wolf, A.J.; Bose, N.; Chan, A.S.; Magee, A. S.; Danielson, M. E.; Weiss, A.; Vasilakos, J.P.; Underhill, D.M. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature, 2011, 472 (7344), 471-5.
87. Underhill, D.M.; Rossnagle, E.; Lowell, C.A.; Simmons, R.M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood, 2005, 106 (7), 2543-50.
88. Rosas, M.; Liddiard, K.; Kimberg, M.; Faro-Trindade, I.; McDonald, J.U.; Williams, D.L.; Brown, G.D.; Taylor, P.R. The induction of inflammation by dectin-1 in vivo is dependent on myeloid cell programming and the progression of phagocytosis. J. Immunol.,2008, 181 (5), 3549-57.
89. Wei, W.C.; Su, Y.H.; Chen, S.S.; Sheu, J.H.; Yang, N.S. GM-CSF plays a key role in zymosan-stimulated human dendritic cells for activation of Th1 and Th17 cells. Cytokine, 2011, 55 (1), 79-89.
90. Gross, O.; Gewies, A.; Finger, K.; Schafer, M.; Sparwasser, T.; Peschel, C.; Forster, I.; Ruland, J. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature, 2006, 442 (7103), 651-6.
91. LeibundGut-Landmann, S.; Gross, O.; Robinson, M. J.; Osorio, F.; Slack, E.C.; Tsoni, S.V.; Schweighoffer, E.; Tybulewicz, V.; Brown, G.D.; Ruland, J.; Reis e Sousa, C. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nature Immunol., 2007, 8 (6), 630-8.
92. Rogers, N.C.; Slack, E.C.; Edwards, A.D.; Nolte, M.A.; Schulz, O.; Schweighoffer, E.; Williams, D.L.; Gordon, S.; Tybulewicz, V.L.; Brown, G.D.; Reis e Sousa, C. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity, 2005, 22 (4), 507-517.
93. Acosta-Rodriguez, E.V.; Rivino, L.; Geginat, J.; Jarrossay, D.; Gattorno, M.; Lanzavecchia, A.; Sallusto, F.; Napolitani, G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunol., 2007, 8 (6), 639-46.
94. Chamilos, G.; Ganguly, D.; Lande, R.; Gregorio, J.; Meller, S.; Goldman, W.E.; Gilliet, M.; Kontoyiannis, D.P. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PloS one, 2010, 5 (9), e12955.
95. Kock, G.; Bringmann, A.; Held, S.A.; Daecke, S.; Heine, A.; Brossart, P. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone. Blood, 2011, 117 (13), 3569-74.
96. Hernanz-Falcon, P.; Joffre, O.; Williams, D. L.; Reis e Sousa, C. Internalization of Dectin-1 terminates induction of inflammatory responses. Eu. J. Immunol., 2009, 39 (2), 507-13.
97. Goodridge, H.S.; Simmons, R.M.; Underhill, D.M. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol., 2007, 178 (5), 3107-15.
98. Slack, E.C.; Robinson, M.J.; Hernanz-Falcon, P.; Brown, G.D.; Williams, D.L.; Schweighoffer, E.; Tybulewicz, V.L.; Reis e Sousa, C. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eu. J Immunol., 2007, 37 (6), 1600-12.
99. Gringhuis, S.I.; den Dunnen, J.; Litjens, M.; van der Vlist, M.; Wevers, B.; Bruijns, S.C.; Geijtenbeek, T.B. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat. Immunol., 2009, 10 (2), 203-13.
100. Gantner, B.N.; Simmons, R.M.; Canavera, S.J.; Akira, S.; Underhill, D.M. Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2. J. Exp. Med., 2003, 197 (9), 1107-1117.
101. Dillon, S.; Agrawal, S.; Banerjee, K.; Letterio, J.; Denning, T.L.; Oswald-Richter, K.; Kasprowicz, D.J.; Kellar, K.; Pare, J.; van Dyke, T.; Ziegler, S.; Unutmaz, D.; Pulendran, B. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigenpresenting cells and immunological tolerance. J. Clin. Invest., 2006, 116 (4), 916-928.
102. Osorio, F.; LeibundGut-Landmann, S.; Lochner, M.; Lahl, K.; Sparwasser, T.; Eberl, G.; Reis e Sousa, C. DC activated via dectin-1 convert Treg into IL-17 producers. Eu. J. Immunol., 2008, 38 (12), 3274-3281.
103. Tian, J.; Ma, J.; Wang, S.; Yan, J.; Chen, J.; Tong, J.; Wu, C.; Liu, Y.; Ma, B.; Mao, C.; Jiao, Z.; Shao, Q.; Lu, L.; Xu, H. Increased expression of mGITRL on D2SC/1 cells by particulate beta-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation. Cell. Immunol., 2011, 270 (2), 183-7.
104. Taylor, P.R.; Brown, G.D.; Herre, J.; Williams, D.L.; Willment, J.A.; Gordon, S. The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J. Immunol., 2004, 172 (2), 1157-62.
105. Kankkunen, P.; Teirila, L.; Rintahaka, J.; Alenius, H.; Wolff, H.; Matikainen, S. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J. Immunol., 2010, 184 (11), 6335-42.
106. Li, X.; Utomo, A.; Cullere, X.; Choi, M.M.; Milner, D.A., Jr.; Venkatesh, D.; Yun, S.H.; Mayadas, T.N. The beta-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe, 2011, 10 (6), 603-15.
107. Stubbs, A.C.; Martin, K.S.; Coeshott, C.; Skaates, S.V.; Kuritzkes, D.R.; Bellgrau, D.; Franzusoff, A.; Duke, R.C.; Wilson, C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med., 2001, 7 (5), 625-9.
108. Soto, E.R.; Caras, A.C.; Kut, L.C.; Castle, M.K.; Ostroff, G.R. Glucan particles for macrophage targeted delivery of nanoparticles. J. Drug Deliv., 2012, 2012, 143524.